NDC Product
Drug For Further Processing- Generic Name
- Olanzapine And Samidorphan L-malate
- Dosage Form
- Tablet, Film Coated
- Route
- N/A
- Marketing
- DRUG FOR FURTHER PROCESSING
Active Listing
LYBALVI 15 mg / 10 mg Oral Tablet
RxNorm 2570404 NDC Crossover
NDC Directory Crossover & Product Mapping
The following National Drug Codes (NDCs) are directly associated with the clinical concept for LYBALVI 15 mg / 10 mg Oral Tablet (RxCUI 2570404). This crossover tool provides a verified mapping between standardized RxNorm clinical drug definitions and the specific manufactured products listed in the FDA NDC directory.
Healthcare professionals, pharmacists, and data analysts use this list to identify various brand names, labelers, and commercial packaging variations linked to this semantic clinical drug concept. Each entry below represents a commercial product that fulfills the requirements of this specific clinical identifier.
